After the close, Abiomed, Inc. (NASDAQ: ABMD) said it received 510(k) clearance from the FDA for its Impella 5.0 and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE